Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Outlook and balance sheet looking solid

SKS Technologies Group
3:27pm
February 24, 2025
SKS reported a strong 1H25 result, delivering NPAT of $5.8m (up 216% on the pcp), a ~13.7% beat vs MorgansF $5.1m. The company delivered solid PBT margin expansion and record cash generation, ending the period with cash of $19.6m. The group also upgraded its FY25 guidance and is now expecting PBT of ~$18.2m. We upgrade our FY25-27F EPS forecasts by 7%/5%/2% respectively to reflect the upgrade to SKS revised margin guidance. This sees our blended DCF/P/E-based price target increase to $2.30 (from $2.15) and we maintain our Add rating.

It’s now a 5-year marathon, not a sprint

NEXTDC
3:27pm
February 24, 2025
NXT’s 1H25 result and outlook were largely as expected. The key challenge for investors remains the tradeoff between NXT investing now to setup the business for a much greater size (higher OPEX now) and the fact that they are investing ahead of revenue growth (higher OPEX is a short-term EBITDA drag). NXT needs to execute well now, on commitments already made, to remain a preferred digital supplier, and continue benefiting from the decades of digital infrastructure growth which is yet to come. Incidentally, a ~$200m+ increase in revenue is already contracted so this is just a timing challenge. We see building a solid foundation as the best way to create value, but acknowledge it can create a jittery investor base, in the short term. Add retained, PT reduced to $18.80.

1H25 Result: Getting comfortable

Adairs
3:27pm
February 24, 2025
Adairs’ 1H25 result was broadly in line with our expectations, with underlying EBIT (pre-AASB 16) up 10% to $33.0m. This was driven by strong sales in Adairs and Mocka Australia, offset by weakness in Focus and Mocka NZ. Margins were well managed driven by cost efficiencies from the National Distribution Centre (NDC) and implementation of the new warehouse management system. The positive trading momentum in Adairs has continued into the second half with sales up an impressive 15.2%; we expect this to moderate for the balance of the half. Ongoing efficiencies in the NDC will help offset inflationary cost pressures and margin headwinds. We forecast EBIT for Adairs brand just shy of 10%. We have revised our EBIT down 3% and 4% respectively, but have increased our price target 10c to $2.85 based on higher peer multiples. We retain our ADD rating.

1H25 Result: Don’t dream it’s over

Lovisa
3:27pm
February 24, 2025
The pace of store rollout has started to accelerate after a period of consolidation, notably in the US over the past two years. We believe Lovisa is poised to hit the landmark of 1,000 stores before the end of the current half, possibly by the time the outgoing CEO Victor Herrero hands over the reins on 31 May. This underscores what we see as the most important element of the Lovisa investment case: the business has a subscale presence in almost every one of the 50 markets in which it operates and significant long-term growth potential in each. We believe the platform for long-term growth is getting stronger all the time. We reiterate our ADD rating. Our target price moves from $36 to $35. LFL sales in 1H25 were less than we had expected at +0.1% (MorgansF: +1.0%) but accelerated to +3.7% in the first 7 weeks of 2H25. This flowed through to 3% lower EBIT than forecast, despite gross margins exceeding our estimate by 90 bps. Lead coverage of Lovisa transfers to Emily Porter with this note.

Trading opportunity emerges with share price fall

Polynovo
3:27pm
February 24, 2025
PNV posted its 1H25 result which was in line with expectations. However, the share price fell sharply (down 8%) which we found surprising and believe has created a buying opportunity. Our forecast growth of 29% for FY25 appears achievable driven by regional expansion and additional indications. We have made no changes to forecasts or TP. Add recommendation maintained.

It’s still tough out there

Reece
3:27pm
February 24, 2025
REH’s 1H25 result was slightly weaker than expected with the housing outlook in both ANZ and the US remaining soft. Key positive: Balance sheet remains healthy with ND/EBITDA (ex-leases) at 0.8x, leaving capacity for ongoing growth investments that will benefit the business over the long term. Key negatives: Volumes and margins were lower in both ANZ and the US; Increased competition has led to market share loss in the US; Cost inflation remains a headwind. We decrease FY25-27F EBITDA by between 2-3%. Our target price falls to $18.70 (from $19.95) and with a 12-month forecast TSR of -1%, we upgrade our rating to Hold (from Reduce). While we continue to see REH as a good business with a strong culture and long track record of growth, the outlook for housing in the near-term remains uncertain despite a likely peak in central bank interest rates in both Australia and the US. REH will also need to respond to aggressive competition in the US, which also adds to the uncertainty on the earnings outlook.

All weather steel cycle performance, with yield

Stanmore Resources
3:27pm
February 24, 2025
Key CY24 financials beat our expectations driven by better realisations/ revenues. The US 6.7c dividend was a positive surprise, helped by a robust balance sheet and a material step down in 2025 capex as internal investment completes. CY25 guidance was materially better than our conservative expectations. SMR trades at ~0.65x P/NPV reflecting depressed investor interest and opacity in the global steel outlook. With a robust balance sheet, and dividends through the cycle, we think SMR offers a compelling option over steel market upside in time for patient investors.

Will organisational reshuffles

Ramsay Health Care
3:27pm
February 24, 2025
Since taking over the reins last Dec, CEO Natalie Davis has started running a ruler over operations, flagging senior leadership changes, updating the operational structure and writing down goodwill related to Elysium mental health business in the UK. Preliminary 1HFY25 results have also been released, which sees underlying operating income decline 1-3% on pcp, and management no longer expecting NPAT growth in FY25. At this early stage, it is difficult to assess if adjustments in operational strategy will have the desired impact, so we continue to remain cautious. We adjust FY25-27 earnings lower, mainly in out years, with our price target decreasing to A$37.74. Hold. CFO Martyn Roberts and Australia CEO Carmel Monaghan will be exiting stage left, with Mr Roberts resigning to “pursue other opportunities” and Ms Monaghan retiring mid-2025. Both will remain with the company during a transition phase. An updated operational structure, which aims to “strengthen the group’s focus on its core Australian hospital business, while building the capabilities necessary to drive transformation and shareholder value”, is slated to be implemented by mid-25 with key changes including: RHC will take a A$291m post-tax goodwill impairment of Elysium, driven by continued occupancy challenges in mental health rehabilitation and neurological services, as well as a slower than planned ramp up in occupancy at new site, partially offset by the increase in valuation for UK Hospitals driven by an improved tariff outlook in 2004/05 and public/private partnership momentum. In an attempt to improve Elysium’s performance, a COO commended in Jan-25, targeting “operational rigour” with a “focus on financial outcomes”. In addition, consultants have been hired to “identify initiatives to improve profitability”. A A$64.5m tax liability provision release for Ramsay Santé will also be taken, as the time period to hold the provision has lapsed.

NEU adds another two zombie designations

Neuren Pharmaceuticals
3:27pm
February 24, 2025
NEU has announced the granting of FDA’s Rare Pediatric Disease Designation (RPD) for both Pitt Hopkins (PH) and Angelman Syndrome (AS), both neurological disorders which emerge in early childhood and currently have no approved treatments. These designations allow companies to apply for various incentives, including the highly-prized Priority Review Voucher (PRV) which awards RPD participants a voucher which can be used to accelerate the FDA’s review process, or can opt to on-sell to another drug developer to use. However, there remains uncertainty under current legislation where the PRV program was active up until September 2024 but has not since been reauthorised. The sunsetting of incentives currently only allows the awarding of the vouchers for approved designations up until late 2026, but seemingly not the qualifying tickets to entry which it continues to award. Given the time it takes to run Ph3 pivotal trials along with the NDA submission process, the designations are effectively zombie designations with no material benefit unless US congress reauthorise the program. A bill introduced in December 2024 (with bipartisan support) which would have extended the sunset date for another 4+ years ran into political challenges and ultimately stripped back many provisions which included the PRV extension. We note that congress has since passed several of the bills originally stripped out of the continuing resolutions, which gives some degree of hope for the program in the near-term. However, from our searches we cannot find any current commentary from the FDA or heard of this program being on the ticket for discussion at the congressional level at this stage.

1H25 earnings: From holding the ball to tightening the reins

Tabcorp Holdings
3:27pm
February 24, 2025
TAH’s 1H25 result was its most encouraging update for some time prompting a positive share price reaction on the day. The appointment of Gill McLachlan as CEO is a key catalyst for driving change, as reflected in his first interim result. Despite softer turnover, total domestic wagering revenue (pre-VRI interest) rose 1%, supported by strong cash performance and resilient digital yields. Encouragingly, FY25 OpEx savings guidance increased from $20m to $30m (MorgansF: $693m) while CapEx and D&A guidance were also revised downwards. Following the result, we have raised our earnings forecasts by 3.2% in FY25 and 1.4% in FY26. Our key takeaway from the investor call is a notable shift in sentiment compared to the previous year. While near-term wagering conditions may appear choppy, we see long-term potential, supported by a series of specialised hires aimed at maximising value from TAH's existing asset base. We upgrade TAH to an Add recommendation and increase our price target to $0.75.

News & Insights

From Houthi attacks on Suez Canal shipping to Trump’s Operation Rough Rider and Iran’s nuclear facility strikes, explore how these events shape oil prices.

At the beginning of the week, I was asked to write something about Iran. When I started looking at what had been happening , I realised that what we were talking about begins with an action by a proxy of Iran back in November 2023. How  that was initially handled with the Biden regime, and how then it was dealt with  deftly by Trump this year,   in turn led to  the need for an attack on Iran's nuclear facility.

Winston Churchill noted in his first volume of his history of the Second World War that it was important to understand that the United States is primarily a naval power. Indeed, the US remains the world dominant naval power. As such, two major strategic concerns remain for the US : the control of the Suez Canal and the Panama Canal .

To the US The idea that another country might block access to either of these must be intolerable. Yet what began happening, beginning on the 19th November 2023, was that , Houthi rebels that controlled a the northern part of a small country in southwestern Arabia, began to act. These Houthi rebels were acting as a proxy for Iran. They were funded by Iran, and armed with Ship-killing rockets, by Iran.

By February 2024, they had attacked 40 ships which had been attempting to sail northwards towards the Suez Canal. By March 2024, 200 ships had been diverted away from the Suez Canal and forced to make the longer and more expensive voyage around the Cape of Good Hope of South Africa. At this point, I think The Economist magazine said that this was the most severe Suez crisis since the 1950s.

The U.S. did respond. On the 18th December 2023, the U.S. had announced an international maritime force to break the Houthi blockade. On the 10th January, the UN National Security Council adopted a resolution demanding a cessation of Houthi attacks on merchant vessels.

As of the 2nd January 2024, the Houthis had already recorded 931 American and British airstrikes against sites in Yemen. Then Trump came to power. To Trump, the idea of the proxy of Iran blockading the Suez Canal could not be tolerated.

From the 15th March 2025, Trump began "Operatation  Rough Rider". This was named for the cavalry commanded by the then-future President Theodore Roosevelt, who charged up San Juan Hill in Cuba during the Spanish-American War of 1898. The U.S. then hit the Houthis with over a thousand airstrikes. So they were bombing at ten times the rate they previously had been. The result of that was that by the 6th March 2025, Trump announced that the Houthis, these proxies of Iran, had capitulated as part of a ceasefire brokered by Oman. This directly led to the main game.

It was obvious that the decision to do the unthinkable, and block the Suez Canal, had come from Iran.
What other unthinkable things was Iran considering?

It is obvious that Trump now believed that the next unthinkable thing that Iran was considering was nuclear weapons. As Iran's other proxies collapsed, Iran's air defence collapsed. In turn, this gave Trump the room to act, and he took it. He launched a bombing raid which severely disabled Iran's nuclear capacity. Some say it completely destroyed it.

Iran retaliated by launching 14 rockets at the American base in Qatar, warning the Americans this was going to happen, and this had no other effect than allowing Iran to announce a glorious victory by themselves over the Americans. Iran had thought the unthinkable and had achieved what was, to them, as a result, an unthinkable reverse.

The ceasefire that has followed has been interpreted by markets as a relief from major risk. Now, the major effect of this on markets has been a dramatic rocketing in the oil price, followed by a fall in the oil price. So I thought I’d look at the fundamentals of the oil price, from running two of my models of the Brent price, using current fundamentals.

Now, the simplest model that I’ve got explains 63% of monthly variation of the Brent oil price. And it’s based on two things. One is the level of stocks in the U.S., which are published every week by the Energy Information Administration .  Those stocks are  down a bit in the most recent months because this is the summer driving season where oil stocks are being drawn down to provide higher demand for gasoline. So that’s a positive thing. And the other thing that I’ve been talking about this year is that I think  we’re going to see a steady fall in the U.S. dollar, and that’s going to generate the beginning of a recovery in commodities prices. So if I also put the U.S. dollar index into this model, it gives me an equilibrium model now of $78.96. And that’s about $US12  higher than the oil price was this morning.

If I strengthen that model by adding the U.S. CPI, because, you know, the cost of production cost of oil raises over time, that increases the power of the model . And that lifts the equilibrium price very considerably to $97 a barrel, which is $30 a barrel higher than it currently is. So I regard that as my medium-term model, and the first one is my short-term model.

What’s really interesting is that the U.S. dollar  has continued to fall.  That puts further upward pressure  on the oil price. So in spite of this crisis having been solved, I think we’re going to see more upward price action on the oil price by the end of the year.

Read more
The US economy is growing strongly at 2.34% in Q2 2025 but is expected to slow to 1.4% in 2025, with falling interest rates and a weaker US dollar likely to boost commodity prices, benefiting Australian markets. Michael Knox discusses.

We think the US economy is currently experiencing solid growth, with data from the Chicago Fed  National Activity Index indicating an annual growth rate of just above  2%. This aligns with projections from other parts of the Federal Reserve System, such as the New York Fed. The New York Fed’s weekly Nowcast, updated every Friday, estimates that for the second quarter of 2025, the US economy is growing at an annualised rate of 2.34%, surpassing the 2% mark. This robust growth is consistent with our model’s view that the US economy is now performing strongly. However, we anticipate a slowdown in the second half of 2025.

On 18 June the Fed released its Summary of Economic Projections  with the Federal Reserve’s  forecasting US GDP growth to drop to 1.4% in 2025, down from their March estimate of 1.7%. Looking further ahead, growth is expected to pick up slightly to 1.6% in 2026 and 1.8% in 2027, aligning with the long-term trend growth rate of around 1.8%. We believe this recovery trend could be even  higher,  driven by reduced regulation under the second Trump administration and aggressive tax write-offs for companies building factories in the US, allowing 100% write-offs for equipment and buildings in the first year. This policy should foster stronger systemic growth.

Economic Projections of the Federal Reserve

The Fed expects that as the economy slows,  unemployment is projected to rise to 4.5% from the current level of 4.2%. Inflation, measured by the Consumer Price Index (CPI), is running at 3.5% this year, approximately 50 basis points higher than the Personal Consumption Expenditures (PCE) index of 3.0%, with 1.6% of this  inflation  attributed to tariffs. The Fed expects PCE Inflation  to ease to 2.4% in 2026 and 2.1% in 2027. The Federal Reserve anticipates cutting the effective  federal funds rate, currently at 433 basis points (according to the New York Fed), by 50 basis points by the end of 2025, followed by an additional 25 basis points in each of the next two years. This aligns with our own Fed Funds rate  model’s current equilibrium federal funds rate of  3.85% . The Fed Outlook  supports our scenario of a slowing US economy and rate cuts in the second half of 2025 and beyond. A falling US dollar is then expected to exert upward pressure on commodity prices, benefiting Australian Equity markets.

Taking questions during the Press Conference after releasing the Fed statement  ,Federal Reserve Chair Jay Powell,   addressed the certainty and uncertainty surrounding the inflationary effects of tariffs. Initially, at the start of 2025, the inflationary impact of tariff policies was unclear, but three months of favourable inflation data have provided this clarity, indicating that the inflationary effects are less severe than anticipated. Powell noted that the Feds own uncertainty on the inflationary effects of  tariffs  peaked in April 2025, and the Federal Reserve now has a clearer understanding that  the inflation effects, are lower than initially expected.

The Fed view  supports our own scenario of a slowing US economy in the second half of 2025, allowing for Fed rate cuts  . This in turn should then lead to  a falling US dollar, which we in turn  expect to drive rising commodity prices.

Read more
The Your Wealth publication is our half yearly scrutiny into current affairs for wealth management. Our latest Issue 29 is out now.

The second half of 2025 will be an interesting time for everyone. Geopolitical uncertainty prevails. How will all of this impact the Australian investor and in particular, their wealth and retirement savings? Whether you are an accumulator, saving for short- and long-term goals, or a retiree, hoping for a comfortable retirement, the ability to manage this uncertainty will be key.

When we published the previous Your Wealth – First Half 2025, the Division 296 Bill (Div296) was also facing uncertainty. The Bill was eventually blocked in the Senate prior to the Federal Election. The Labor Party succeeded in winning so it’s Ground Hog Day for Div296. The Government doesn’t have the numbers in the Senate to pass the Bill without support from other parties. The Greens are the likely negotiating party but will undoubtably have their own agenda. Regardless, there is a high probability this legislation will be passed once Parliament resumes.

Our message to our clients is to wait until we know more details and to not act in haste.

In addition to our Feature Article which provides further insights on Div296, this edition also Spotlights the Aged Care changes due this year, with the start date pushed back to 1 November.

We hope readers enjoy this edition of Your Wealth.


Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
Read more